Dag Sigurd Fosmark

Increased serum levels of the specific advanced glycation end product methylglyoxal-derived hydroimidazolone are associated with retinopathy in patients with type 2 diabetes mellitus

Dag Sigurd Fosmark, Peter A. Torjesen, Bente Kilhovd et al. · Metabolism · 2006 · 123 citations · Full text

Metabolic Syndrome, Diabetic Retinopathy, Ocular Disease +9

Low cumulative incidence of proliferative retinopathy in childhood-onset type 1 diabetes: a 24-year follow-up study

Torild Skrivarhaug, Dag Sigurd Fosmark, Lars C. Stene et al. · Diabetologia · 2006 · 60 citations · Full text

Proliferative Retinopathy, Diabetic Retinopathy, Ocular Disease +10

Hand, shoulder and back stiffness in long-term type 1 diabetes; cross-sectional association with skin collagen advanced glycation end-products. The Dialong study

Kristine Bech Holte, Niels Gunnar Juel, Jens Ivar Brox et al. · Journal of Diabetes and its Complications · 2017 · 56 citations

Diabetes Management, Long-term Type 1, Diabetes Epidemiology +7

Increased retinopathy occurrence in type 1 diabetes patients with increased serum levels of the advanced glycation endproduct hydroimidazolone

Dag Sigurd Fosmark, Jens Petter Berg, Aase‐Brith Jensen et al. · Acta Ophthalmologica · 2008 · 28 citations · Full text

Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case‐control study

Dag Sigurd Fosmark, Ragnheiður Bragadóttir, Ingar Stene‐Johansen et al. · Acta Ophthalmologica Scandinavica · 2007 · 24 citations · Full text